Trading Options with an Edge
Select Page

CERE

Search by
TICKER SYMBOL

Cerevel Therapeutics Holdings Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

24.94

0.5

(2.046%)

Volume:

280,089

52 week range:

12.01 - 46.16

Market Cap:

3.698B

Company Description:

Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several pre-clinical compounds with the potential to treat a range of neuroscience diseases, including Parkinson's, epilepsy, schizophrenia and substance use disorder. Headquartered in Cambridge, Mass., Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.